Pvmed Raises Us $14 Million Series A Funding From Cherami, Philips, Jhf, Cococapital, And Strategy Capital

Dec 23, 2022•almost 3 years ago

Amount Raised

$14 Million

Round Type

series a

GuangzhouMedicalBiotechnologyHealth Care

Investors

Strategy CapitalCococapital CorporationJhf InvestmentCherami Investment Group,

Description

Perception Vision Medical Technologies Co., Ltd. (PVmed), a global artificial intelligence (AI) cancer treatment company, headquartered in Guangzhou, China, has secured US $14 million (RM 100 million) in Series A funding from investors including Cherami Investment Group, Philips, JHF Investment, COCOCAPITAL Corporation, and Strategy Capital. The funding will enable the company to further develop its AI cancer treatment product portfolio and ecosystem. It will also accelerate the adoption of the company's AI-defined cancer surgery and radiotherapy workflow software and hardware products by hospitals and medical technology companies.

Company Information

Company

PVmed

Location

Guangzhou, Guangdong, China

About

PVmed, pioneered in the field of medical technology, provides the state-of-art customized solutions to the healthcare industry. We aim for auxiliary diagnosis and treatment based on self-developed AI-enhanced medical image processing systems. Developed strategic partnerships with leading hospitals, research institutes, and device manufacturers globally, solutions are full clinical evidence-based and built on quality-labeled medical data and cutting-edge algorithms. Our mission is to empower physicians to deliver the highest standard of care to patients with consistency and efficiency. We are the ones pushing the edge of human knowledge and understanding. Current products include: Intelligent Radiationtherapy System and Intelligent Medical Image Post-processing System. For business or research purposes, please email contact@pvmedtech.com.

Related People

2 contacts

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Tech investment trends